Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry
Affiliations
- PMID: 15027457
Item in Clipboard
Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry
Food Drug Law J.
2003.
No abstract available
Similar articles
-
Realizing two-tiered innovation policy through drug regulation.Stanford Law Rev. 2006 Feb;58(4):1221-50. Stanford Law Rev. 2006. PMID: 16685807 No abstract available.
-
The ongoing regulation of generic drugs.N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193. N Engl J Med. 2007. PMID: 18003956 No abstract available.
-
The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.Food Drug Law J. 2003;58(1):51-80. Food Drug Law J. 2003. PMID: 12739584 No abstract available.
-
The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?J Contemp Health Law Policy. 1996 Spring;12(2):607-36. J Contemp Health Law Policy. 1996. PMID: 8666736 Review. No abstract available.
-
The case for compulsory licensing during COVID-19.J Glob Health. 2020 Jun;10(1):010358. doi: 10.7189/jogh.10.010358. J Glob Health. 2020. PMID: 32509289 Free PMC article. Review. No abstract available.